Theta Research
  • Home
  • Graph
  • CompaniesPro
  • Pulse
  • Shipped
  • Engine

For serious investors who think in systems.

AboutAbout
ToolsOption LabDashboard
FeedbackRoadmap
© 2026 theta.md
← Back to Research

CoreWeave Q1 2026: Beat the Numbers, Lost the Narrative

May 10, 2026|Quant Research|Scenario Analysis
CRWVEarningsNeocloudAI InfrastructureAPLDNBIS

CoreWeave beat Q1 consensus by 5.5% and reported $99.4B RPO, but stock fell 11.68% on disappointing Q2 guidance. We score 10 pre-event predictions (avg Brier 0.152), analyze the guidance-driven selloff, and identify thesis updates for CRWV, APLD, and NBIS.

Pre-Event Setup

CoreWeave entered Q1 2026 earnings on May 7 with a stock price of $126-129, up 75% YTD, carrying a troubling 3/4 recent-quarter miss rate. Our pre-event report identified the core tension: the bull narrative (RPO expansion, Meta/Anthropic diversification) was real but already priced in, while the bear signal (historical misses, deepening losses, rising interest expense) was underweighted.

What Actually Happened

CoreWeave delivered a strong Q1 beat on every reported metric:

MetricExpectedActualVerdict
Revenue$1.97B consensus$2.078BBeat +5.5%
RPO$90-95B modeled$99.4BMassive beat
Adj EBITDA margin~55%56%In-line
Adj Operating Income$0-40M guide$21MPositive
Interest expense$510-590M$536MWithin range

Yet the stock fell 10% after-hours and closed down 11.68% the next day at $113.80.

The disconnect: Q2 guidance. CoreWeave guided Q2 revenue at $2.45-2.6B (mid $2.53B), trailing the $2.69B LSEG consensus by 6%. Combined with a raised capex floor ($31-35B vs $30-35B prior), the market message was clear: growth is accelerating but profitability is not keeping pace. The era of "beat revenue at any cost" is over — investors now demand margin expansion.

Prediction Scoring (Brier Method)

#PredictionConfResultBrier
1Revenue >= $1.97B consensus0.35TRUE0.423
2Revenue >= $1.9B guidance floor0.70TRUE0.090
3RPO > $90B reported0.60TRUE0.160
4Anthropic value disclosed0.40FALSE0.160
5Adj OI positive (>$0)0.55TRUE0.203
6Interest expense > $590M0.20FALSE0.040
7MSFT concentration < 60%0.25FALSE0.063
8Stock moves > 15% in 2 days0.60FALSE0.360
9FY2026 guidance raised > $13B0.10FALSE0.010
10New contract > $3B on call0.10FALSE0.010

Average Brier: 0.152 (lower = better, 0 = perfect)

### Calibration Analysis

Our biggest miss was Prediction #1 — we assigned only 35% confidence to the revenue beat, heavily influenced by the 3/4 historical miss rate and Zacks' bearish preview. The actual result ($2.078B) exceeded even the Scenario 1 "strong beat" threshold of $2.0B. Lesson: the 3/4 miss pattern was a weak predictor once Meta and Anthropic contracts began ramping.

Prediction #8 was our second-worst score — we gave 60% confidence to a >15% move based on 18.71% implied vol, but the actual move was -11.68%. The market priced in significant risk but the selloff was orderly, not panicked.

The low-confidence predictions (#6, #9, #10) were well-calibrated at 0.10-0.20 confidence, all resolving FALSE as expected.

Thesis Impact

CRWV: The Q1 beat breaks the 3/4 miss pattern and validates the revenue growth engine. But the market has shifted its focus from "can CoreWeave grow?" to "when does CoreWeave earn?" The $115 bear trigger was tested ($113.80 close) — the next session's price action determines whether this is a buy-the-dip or a structural derating.

APLD: CoreWeave's financial health ($21M adj OI, $99.4B RPO) de-risks the Polaris Forge counterparty concern. The APLD monitoring trigger (CRWV credit downgrade) did not fire.

NBIS: CoreWeave's beat raises the competitive bar. NBIS fell 4.18% in sympathy. The message from CoreWeave's results is that runaway growth without operating leverage is no longer sufficient — NBIS faces the same investor scrutiny.

Trade Actions

  • Hold CRWV — beat validates growth, but do not add above $115 given guidance-driven derating risk
  • RPO $99.4B anchors FY2027 bull case (75% recognizable within 4 years)
  • Watch $113.80 level — hold confirms support, break below reopens $95-107 bear range
  • APLD counterparty risk diminished — maintain position
  • Monitor NBIS for margin-expansion catalysts at its own upcoming earnings

Related Articles

Mar 31, 2026

Micron at 5.5x Forward P/E: Cycle Trap or Generational Buy?

Micron dropped 32% in 12 days while posting the best quarter in company history. We dissect three fear catalysts, reconstruct actual P/E data from three historical cycle peaks, and build a verification framework for the central question: is the E about to collapse?

Feb 15, 2026

NVDA: AI Infrastructure Dominance and the Compute Bottleneck

NVIDIA's data center segment continues to benefit from insatiable AI compute demand. We model three scenarios around supply chain constraints, competitive dynamics from AMD/custom silicon, and the HBM supply bottleneck.